Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Relevance of ROS (V-ros UR2 Sarcoma Virus Oncogene Homolog) Aberrations in Solid Tumours

NCT01596374 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.

NCT NCT01596374
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01596374 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Relevance of ROS (V-ros UR2 Sarcoma Virus Oncogene Homolog) Aberrations in Solid Tumours
Lead sponsor
National University Hospital, Singapore
Phase
Observational
Overall status
Unknown status
Start date
August 31, 2011
Completion date
Not reported
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer